冷泉港亞洲2013會議：疫苗設計
Vaccine Design
疫苗設計
2013年6月3-7日 | 蘇州獨墅湖會議酒店
|
科學組委會成員: Michael Good, Griffith University, AUSTRALIA Yiming Shao, Chinese Center for Disease Control and Prevention, CHINA Linqi Zhang, Tsinghua University, CHINA |
主題演講嘉賓:
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
特邀演講嘉賓:
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
會議主題：
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
|
|
聯系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029 Fax: +86-512-62729028 Email: mikeji@cshl.edu Website: www.csh-asia.org |
相關鏈接： 2013年冷泉港亞洲（CSH Asia）會議搶先預覽！
- CGT Asia 第十屆亞洲細胞與基因治療創新峰會通知
- 禮智生物將亮相大灣區腦病中醫藥科創與產學研大會
- NEW-MED 2026生物材料研發及應用峰會通知
- 隱智科儀攜智能儀器解決方案亮相華人生物分析論壇
- 2026生物農藥研發創制與農藥制劑加工研討會通知
- 2026第八屆國際功能醫學創新大會通知
- CGLTS2025北京細胞與基因免疫治療亦莊峰會通知
- 第11屆全國植物生物學與植物逆境生物學研討會通知
- 2026作物高產高效栽培與生態耕作學術研討會通知
- 2026廣西臨床檢驗儀器、試劑與輸血用品展覽會通知
- 北京基爾比攜類器官科研儀器參加BSCB2025學術年會
- 華威中儀邀您參加2025全國海洋微生物學學術研討會
- CBIC 2026細胞生物產業大會邀請函
- 霍爾斯攜經典發酵罐及切向流超濾系統亮相BioONE2025
- 慧榮和亮相中國毒理學會農藥毒理學專委會成立大會
- MCE雙十一類器官專場直播：抗體/試劑盒/染料特惠
- Agrisera講座：WB精準判讀與典型誤區規避
- 斯達特抗體文獻激勵計劃來襲，發論文解鎖階梯式獎勵
- MCE抗體實驗圖PK賽投票通道正式開啟，盲盒等你贏
- 杭州費雪推出新品豬流行性腹瀉（PEDV）單克隆抗體
- Agrisera直播：從抗體選擇到WB全流程優化策略
- MCE中國抗體實驗圖征稿啟示，秀美圖贏AirPods
- 斯達特生物將亮相2025年美國AACR展會，誠邀您蒞臨！
- MCE直播預告：銅死亡的機制探索與醫學應用
- 2024第九屆疫苗中國領導者年會通知
- MCE推出超900種一抗和多種二抗產品，涵蓋熱門靶點
- 丹納赫將收購Abcam以推動生命科學領域研究創新進程
- 睿捷生物新學期新福利，四重優惠限時享
- 佰諾全景科研mIHC病理技術服務年中大促銷火熱來襲
- 西美杰KPL熱銷二抗和底物限時優惠活動已啟動！
Copyright(C) 1998-2025 生物器材網 電話：021-64166852;13621656896 E-mail：info@bio-equip.com